Search research articles
Contact Us
Filters
Showing results (241-250 of 259) with videos related to
Page
of 26
Sort By:
Journal of Inherited Metabolic Disease
|
September 11, 2019
Early neurodevelopmental characterization in children with cobalamin C/defect
Daniela Ricci, Diego Martinelli, Gloria Ferrantini, et al.
JAMA
|
September 11, 1996
Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial
N O Borhani, M Mercuri, P A Borhani, et al.
La Radiologia Medica
|
March 11, 2019
Value of structured reporting in neuromuscular disorders
Francesco Alessandrino, Lara Cristiano, Claudia Maria Cinnante, et al.
Current Medical Research and Opinion
|
July 24, 2001
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial
D R Illingworth, J R Crouse, D B Hunninghake, et al.
The American Journal of Cardiology
|
July 29, 2000
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
J J Kastelein, J L Isaacsohn, L Ose, et al.
JAMA Neurology
|
May 12, 2025
Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical Trial
Krista Vandenborne, Glenn A Walter, Volker Straub, et al.
Clinical Cardiology
|
February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group
L Ose, M H Davidson, E A Stein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
S Ferrari, K Sundby Hall, R Luksch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities
P Picci, T Böhling, G Bacci, et al.
Nature Medicine
|
December 8, 2025
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial
Jennifer M Kwon, Francina Munell, Laure Le Goff, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 259) with videos related to
Sort By:
Page
of 26
Journal of Inherited Metabolic Disease
|
September 11, 2019
Early neurodevelopmental characterization in children with cobalamin C/defect
Daniela Ricci, Diego Martinelli, Gloria Ferrantini, et al.
JAMA
|
September 11, 1996
Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial
N O Borhani, M Mercuri, P A Borhani, et al.
La Radiologia Medica
|
March 11, 2019
Value of structured reporting in neuromuscular disorders
Francesco Alessandrino, Lara Cristiano, Claudia Maria Cinnante, et al.
Current Medical Research and Opinion
|
July 24, 2001
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial
D R Illingworth, J R Crouse, D B Hunninghake, et al.
The American Journal of Cardiology
|
July 29, 2000
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
J J Kastelein, J L Isaacsohn, L Ose, et al.
JAMA Neurology
|
May 12, 2025
Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical Trial
Krista Vandenborne, Glenn A Walter, Volker Straub, et al.
Clinical Cardiology
|
February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group
L Ose, M H Davidson, E A Stein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
S Ferrari, K Sundby Hall, R Luksch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities
P Picci, T Böhling, G Bacci, et al.
Nature Medicine
|
December 8, 2025
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial
Jennifer M Kwon, Francina Munell, Laure Le Goff, et al.
Page
of 26